Titre:
  • Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.
Auteur:McCormack, Mark; Urban, Thomas J; Shianna, Kevin V; Walley, Nicole; Pandolfo, Massimo; Depondt, Chantal; Chaila, Elijah; O'Conner, Gerard D; Kasperavičiūtė, Dalia; Radtke, Rodney A; Heinzen, Erin; Sisodiya, Sanjay M; Delanty, Norman; Cavalleri, Gianpiero L
Informations sur la publication:Pharmacogenomics, 13, 4, page (399-405)
Statut de publication:Publié, 2012-03
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:epilepsy
GWAS
HLA-A 3101
hypersensitivity
lamotrigine
phenytoin
MeSH keywords:Biomarkers, Pharmacological
Carbamazepine -- adverse effects -- therapeutic use
Drug Hypersensitivity -- genetics
Genome-Wide Association Study
HLA-A Antigens -- genetics
Humans
Phenytoin -- adverse effects -- therapeutic use
Polymorphism, Single Nucleotide
Triazines -- adverse effects -- therapeutic use
Note générale:Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1462-2416
info:doi/10.2217/pgs.11.165
info:scp/84857768999
info:pmid/22379998